Search

Author/Creator Allez, M.

1. Early intervention in psoriasis and immune-mediated inflammatory diseases: A hypothesis paper. (April 2015)

Authors:
Girolomoni, G.; Griffiths, C. E. M.; Krueger, J.; Nestle, F. O.; Nicolas, J-F.; Prinz, J. C.; Puig, L.; Ståhle, M.; van de Kerkhof, P. C. M.; Allez, M.; Emery, P.; Paul, C.
Journal:
Journal of dermatological treatment
Issue:
Volume 26:Number 2(2015:Apr.)
Page Start:
103
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Factors associated with pregnancy outcome in anti‐TNF treated women with inflammatory bowel disease. Issue 4 (30th June 2014)

Authors:
Seirafi, M.; de Vroey, B.; Amiot, A.; Seksik, P.; Roblin, X.; Allez, M.; Peyrin‐Biroulet, L.; Marteau, P.; Cadiot, G.; Laharie, D.; Boureille, A.; De Vos, M.; Savoye, G.; Rahier, J.‐F.; Carbonnel, F.; Bonaz, B.; Colombel, J.‐F.; Bouhnik, Y.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 40:Issue 4(2014)
Page Start:
363
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. FRI0167 Alopecia areata occuring during tnf blockers therapy : a french multicentric survey. (23rd January 2014)

Authors:
Tauber, M.; Buche, S.; Berthelot, J.-M.; Aubin, F.; Cohen, J.-D.; Ghislain, P.-D.; Goujon, E.; Jullien, D.; Brixi, H.; Bardin, T.; Jeudy, G.; Guennoc, X.; Martin, A.; Marteau, P.; Allez, M.; Bachelez, H.; Reygagne, P.; Viguier, M.
Journal:
Annals of the rheumatic diseases
Issue:
Volume 72:Supplement 3(2013)
Page Start:
A427
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

4. Impact of vedolizumab therapy on extra‐intestinal manifestations in patients with inflammatory bowel disease: a multicentre cohort study nested in the OBSERV‐IBD cohort. Issue 4 (18th December 2017)

Authors:
Tadbiri, S.; Peyrin‐Biroulet, L.; Serrero, M.; Filippi, J.; Pariente, B.; Roblin, X.; Buisson, A.; Stefanescu, C.; Trang‐Poisson, C.; Altwegg, R.; Marteau, P.; Vaysse, T.; Bourrier, A.; Nancey, S.; Laharie, D.; Allez, M.; Savoye, G.; Gilletta, C.; Gagniere, C.; Vuitton, L.
Other Names:
Amiot Aurelien investigator.; Gagniere Charlotte investigator.; Serrero Melanie investigator.; Grimaud Jean‐Charles investigator.; Peyrin‐Biroulet Laurent investigator.; Zallot Camille investigator.; Bigard Marc‐Andre investigator.; Filippi Jerome investigator.; Hebuterne Xavier investigator.; Pa...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 4(2018)
Page Start:
485
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Long‐term efficacy and safety of ustekinumab in 122 refractory Crohn's disease patients: a multicentre experience. Issue 5 (8th January 2018)

Authors:
Wils, P.; Bouhnik, Y.; Michetti, P.; Flourie, B.; Brixi, H.; Bourrier, A.; Allez, M.; Duclos, B.; Serrero, M.; Buisson, A.; Amiot, A.; Fumery, M.; Roblin, X.; Peyrin‐Biroulet, L.; Filippi, J.; Bouguen, G.; Abitbol, V.; Coffin, B.; Simon, M.; Laharie, D.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 47:Issue 5(2018)
Page Start:
588
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

7. One‐year effectiveness and safety of vedolizumab therapy for inflammatory bowel disease: a prospective multicentre cohort study. Issue 3 (8th June 2017)

Authors:
Amiot, A.; Serrero, M.; Peyrin‐Biroulet, L.; Filippi, J.; Pariente, B.; Roblin, X.; Buisson, A.; Stefanescu, C.; Trang‐Poisson, C.; Altwegg, R.; Marteau, P.; Vaysse, T.; Bourrier, A.; Nancey, S.; Laharie, D.; Allez, M.; Savoye, G.; Moreau, J.; Vuitton, L.; Viennot, S.
Other Names:
Amiot Aurelien investigator.; Gagniere Charlotte investigator.; Serrero Melanie investigator.; Grimaud Jean‐Charles investigator.; Peyrin‐Biroulet Laurent investigator.; Zallot Camille investigator.; Bigard Marc‐Andre investigator.; Filippi Jerome investigator.; Hebuterne Xavier investigator.; Pa...
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 46:Issue 3(2017)
Page Start:
310
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study. (October 2015)

Authors:
Denis, B.; Lafaurie, M.; Donay, J.-L.; Fontaine, J.-P.; Oksenhendler, E.; Raffoux, E.; Hennequin, C.; Allez, M.; Socie, G.; Maziers, N.; Porcher, R.; Molina, J.-M.
Journal:
International journal of infectious diseases
Issue:
Volume 39(2015:Oct.)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Prevalence, risk factors, and impact on clinical outcome of extended-spectrum beta-lactamase-producing Escherichia coli bacteraemia: a five-year study. (October 2015)

Authors:
Denis, B.; Lafaurie, M.; Donay, J.-L.; Fontaine, J.-P.; Oksenhendler, E.; Raffoux, E.; Hennequin, C.; Allez, M.; Socie, G.; Maziers, N.; Porcher, R.; Molina, J.-M.
Journal:
International journal of infectious diseases
Issue:
Volume 39(2015:Oct.)
Page Start:
1
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Randomised clinical trial: vercirnon, an oral CCR9 antagonist, vs. placebo as induction therapy in active Crohn's disease. Issue 10 (23rd September 2015)

Authors:
Feagan, B. G.; Sandborn, W. J.; D'Haens, G.; Lee, S. D.; Allez, M.; Fedorak, R. N.; Seidler, U.; Vermeire, S.; Lawrance, I. C.; Maroney, A. C.; Jurgensen, C. H.; Heath, A.; Chang, D. J.
Journal:
Alimentary pharmacology & therapeutics
Issue:
Volume 42:Issue 10(2015)
Page Start:
1170
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗